Distinct Methylation Changes at the IGF2-H19 Locus in Congenital Growth Disorders and Cancer

Background Differentially methylated regions (DMRs) are associated with many imprinted genes. In mice methylation at a DMR upstream of the H19 gene known as the Imprint Control region (IC1) is acquired in the male germline and influences the methylation status of DMRs 100 kb away in the adjacent Insulin-like growth factor 2 (Igf2) gene through long-range interactions. In humans, germline-derived or post-zygotically acquired imprinting defects at IC1 are associated with aberrant activation or repression of IGF2, resulting in the congenital growth disorders Beckwith-Wiedemann (BWS) and Silver-Russell (SRS) syndromes, respectively. In Wilms tumour and colorectal cancer, biallelic expression of IGF2 has been observed in association with loss of methylation at a DMR in IGF2. This DMR, known as DMR0, has been shown to be methylated on the silent maternal IGF2 allele presumably with a role in repression. The effect of IGF2 DMR0 methylation changes in the aetiology of BWS or SRS is unknown. Methodology/Principal Findings We analysed the methylation status of the DMR0 in BWS, SRS and Wilms tumour patients by conventional bisulphite sequencing and pyrosequencing. We show here that, contrary to previous reports, the IGF2 DMR0 is actually methylated on the active paternal allele in peripheral blood and kidney. This is similar to the IC1 methylation status and is inconsistent with the proposed silencing function of the maternal IGF2 allele. Beckwith-Wiedemann and Silver-Russell patients with IC1 methylation defects have similar methylation defects at the IGF2 DMR0, consistent with IC1 regulating methylation at IGF2 in cis. In Wilms tumour, however, methylation profiles of IC1 and IGF2 DMR0 are indicative of methylation changes occurring on both parental alleles rather than in cis. Conclusions/Significance These results support a model in which DMR0 and IC1 have opposite susceptibilities to global hyper and hypomethylation during tumorigenesis independent of the parent of origin imprint. In contrast, during embryogenesis DMR0 is methylated or demethylated according to the germline methylation imprint at the IC1, indicating different mechanisms of imprinting loss in neoplastic and non-neoplastic cells.

[1]  H. Byun,et al.  Examination of IGF2 and H19 loss of imprinting in bladder cancer. , 2007, Cancer research.

[2]  G. Pinto,et al.  11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations. , 2007, The Journal of clinical endocrinology and metabolism.

[3]  R. Weksberg,et al.  Growth Regulation, Imprinted Genes, and Chromosome 11p15.5 , 2007, Pediatric Research.

[4]  M. Negrini,et al.  Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour. , 2007, Human molecular genetics.

[5]  Rolf Ohlsson,et al.  CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Wagschal,et al.  Epigenetic deregulation of imprinting in congenital diseases of aberrant growth. , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[7]  S Apostolidou,et al.  Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. , 2006, Human molecular genetics.

[8]  B. Hamel,et al.  Hypomethylation of the H19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype. , 2006, American journal of human genetics.

[9]  A. Berchuck,et al.  Frequent IGF2/H19 Domain Epigenetic Alterations and Elevated IGF2 Expression in Epithelial Ovarian Cancer , 2006, Molecular Cancer Research.

[10]  M. Bartolomei,et al.  Developmental Profile of H19 Differentially Methylated Domain (DMD) Deletion Alleles Reveals Multiple Roles of the DMD in Regulating Allelic Expression and DNA Methylation at the Imprinted H19/Igf2 Locus , 2006, Molecular and Cellular Biology.

[11]  W. Reik,et al.  Molecular subtypes and phenotypic expression of Beckwith–Wiedemann syndrome , 2005, European Journal of Human Genetics.

[12]  Maria Vernucci,et al.  Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome , 2004, Nature Genetics.

[13]  Wolf Reik,et al.  Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops , 2004, Nature Genetics.

[14]  V. Pant,et al.  Mutation of a Single CTCF Target Site within the H19 Imprinting Control Region Leads to Loss of Igf2 Imprinting and Complex Patterns of De Novo Methylation upon Maternal Inheritance , 2004, Molecular and Cellular Biology.

[15]  A. Feinberg,et al.  The history of cancer epigenetics , 2004, Nature Reviews Cancer.

[16]  M. Ladanyi,et al.  Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. , 2003, Human molecular genetics.

[17]  W. Reik,et al.  Epigenetic modifications in an imprinting cluster are controlled by a hierarchy of DMRs suggesting long-range chromatin interactions. , 2003, Human molecular genetics.

[18]  A. Feinberg,et al.  Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. , 2002, Cancer research.

[19]  J. Herman,et al.  Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours , 2002, The Journal of pathology.

[20]  R. Weksberg,et al.  Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. , 2001, Human molecular genetics.

[21]  W. Reik,et al.  An intragenic methylated region in the imprinted Igf2 gene augments transcription , 2001, EMBO reports.

[22]  W. Reik,et al.  Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19 , 2000, Nature Genetics.

[23]  Victor V Lobanenkov,et al.  Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive , 2000, Current Biology.

[24]  Shirley M. Tilghman,et al.  CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus , 2000, Nature.

[25]  G. Felsenfeld,et al.  Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene , 2000, Nature.

[26]  G. Pfeifer,et al.  Maternal-specific footprints at putative CTCF sites in the H19 imprinting control region give evidence for insulator function , 2000, Current Biology.

[27]  A. Reeve,et al.  Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation , 1999, Oncogene.

[28]  M. Bartolomei,et al.  Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. , 1998, Genes & development.

[29]  T. Moore,et al.  Multiple imprinted sense and antisense transcripts, differential methylation and tandem repeats in a putative imprinting control region upstream of mouse Igf2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Reeve,et al.  Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Hochberg,et al.  Developmentally imprinted genes as markers for bladder tumor progression. , 1996, The Journal of urology.

[32]  W. Reik,et al.  Developmental control of allelic methylation in the imprinted mouse Igf2 and H19 genes. , 1994, Development.